期刊
CURRENT PHARMACEUTICAL DESIGN
卷 18, 期 25, 页码 3721-3730出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138161212802002760
关键词
CD36; stroke; angiogenesis; inflammation; endothelial dysfunction
资金
- NIH grants [HL82511, HL82511-04S1]
Stroke pathology involves multifactorial pro-death responses, including inflammation, oxidative stress, vascular dysfunction, and activation of necrotic and apoptotic pathways. The interruption of a single specific pathway in defined stroke model systems has not been sufficient to address the multifactorial nature of stroke-induced injuries in the human population. CD36 is a class B scavenger receptor that functions in regulating normal physiological and pathological functions. CD36 pathways are activated by several distinct ligands. Convergence of these pathways results in inflammatory responses and endothelial dysfunction, which may be an underlying cause of cardio- and cerebrovascular diseases. The current review describes receptor CD36-ligand interactions relevant to endothelial function and discusses how targeting CD36 may have therapeutic utility in stroke.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据